Viral infections contribute as a cause of 15–20% of all human cancers. Infection by
oncogenic viruses can promote different stages of carcinogenesis. Among many types of …

Human papillomavirus (HPV) infection is recognized as one of the major causes of infection-
related cancer in both men and women. High-risk HPV types are not only responsible for …

Since the publication of the 2018 FIGO Cancer Report, giant strides have been made in the
global effort to reduce the burden of cervical cancer, with the World Health Organization …

Objective: HIV-positive women have higher human papillomavirus (HPV) prevalence and
cervical cancer incidence than HIV-negative women, partly because of HIV's modifying effect …

Background Cervical cancer is the second most common cancer and the leading cause of
cancer death in women in sub-Saharan Africa (SSA). Methods Trends in the incidence of …

Background Coinciding with the release of the first Chinese domestic human papillomavirus
(HPV) vaccine Cecolin in 2019, and the substantial advancements in cervical cancer …

Cytology-based cervical screening had unequivocal success in reducing the incidence and
mortality of cervical cancer in the last century. The recognition of the role of human …

Abstract Background Survival differences across Europe for patients with cancers of breast,
uterus, cervix, ovary, vagina and vulva have been documented by previous EUROCARE …

Cervical cancer still poses a significant global challenge. Developed countries have
mitigated this challenge by the introduction of structured screening programmes and, more …

Background In developing countries, inadequate access to effective screening for cervical
cancer often contributes to the high morbidity and mortality caused by the disease. The …